Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Children receiving Heliox Inhalation in Croup: a randomised controlled trial
ISRCTN ISRCTN82240782
ClinicalTrials.gov identifier
Public title Children receiving Heliox Inhalation in Croup: a randomised controlled trial
Scientific title
Acronym CHIC
Serial number at source N/A
Study hypothesis What effect has Heliox on improving croup score and relieving symptoms in children with croup?
Ethics approval Submitted to the University Hospitals of Leicester (UHL) R&D office and Ethics Committee [UHL 10193]
Study design Randomised double-blind controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Croup (laryngotracheobronchitis)
Participants - inclusion criteria Children, aged six months to five years, presenting to the Emergency Department (ED) with moderate to severe croup (Modified Westley Croup Score of two or more).
Participants - exclusion criteria 1. Children whose oxygen saturation is less than 95%
2. Children with known pre-existing lung or airway disease, congenital heart disease, or features suggesting other causes of stridor, such as peritonsillar abscess, epiglottitis or inhaled foreign body
Anticipated start date 01/03/2007
Anticipated end date 01/03/2010
Status of trial Completed
Patient information material
Target number of participants 142
Interventions Patients will be randomly allocated to receiving ,additionally to the standard croup treatment, either Heliox21 (study group) or Air (control group). Comparison will be made of the primary and secondary outcome measures, comparing all those allocated to Heliox versus those allocated to Air.
Primary outcome measure(s) Modified Westley Croup Score at 30 minutes
Secondary outcome measure(s) 1. Croup score at 15 minutes
2. Respiratory rate at 15, 30 minutes
3. Parents assessment of change on Visual Analog Scale
4. Number of epinephrine nebulisers given
5. Requirement for supplemental oxygen therapy
6. Admission to hospital
7. Intubation rate
8. Length of stay in ED
9. Length of stay in hospital
10. Subsequent use of health services
Sources of funding Not provided at time of registration
Trial website
Publications
Contact name Prof  Timothy  Coats
  Address Emergency Department
Leicester Royal Infirmary
Infirmary Square
  City/town Leicester
  Zip/Postcode LE1 5WW
  Country United Kingdom
  Email tc61@le.ac.uk
Sponsor University Hospitals of Leicester NHS Trust (UK)
  Address Trust Headquarters
Gwendolen House
Gwendolen Road
  City/town Leicester
  Zip/Postcode LE5 4QF
  Country United Kingdom
  Email djr8@le.ac.uk
  Sponsor website: http://www.uhl-tr.nhs.uk/
Date applied 07/10/2006
Last edited 26/06/2008
Date ISRCTN assigned 22/02/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central